Intellia Therapeutics
BiotechnologyCambridge, Massachusetts, United StatesPost-IPO Equity$1.7B total fundingintelliatx.com
Latest funding:$180.0M · Post-IPO Equity (April 29, 2026)
Angel investors who backed Intellia Therapeutics
24 investors in our database backed Intellia Therapeutics.
Kevin Bitterman
Partner
Luke Bagaason, CFA
Manager - Portfolio Valuation
Dennis Ryan
Chief Financial Officer & Managing Director
Dorothy Margolskee
Managing Director
Richard Lau, CFA
Partner
Bruce Booth
Partner
Jason Rhodes
Partner
Jernej Godec
Principal
Alex Harding
Senior Associate
Jean-FranÔøΩEois Formela
Partner
Chelsea Place Johnson
Senior Associate
Ommer Chohan
CFO
Steven Robinette
Principal
Sarah Marriott
Chief Operating Officer
Oleg Nodelman
Founder and Managing Director
Scott Platshon
Investor
Caroline Stout
Partner
Marc-Andre Marcotte, CFA
Partner & COO
Catherine Poulin-Filion
Principal
Michael Sjostrom
Chief Investment Officer
Francois Beaubien
Partner
Howard Riback
Director
Jean-Francois Formela
Partner
James Velissaris
Chief Investment Officer
Infinity Q Capital Management
Who invested in...
See every angel investor and VC behind well-known startups.
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Intellia Therapeutics.
Search investors